Zenflow closed an oversubscribed Series D to commercialize its Spring System after FDA approval, with Cook Medical leading and supporting U.S. distribution.
- Amount
- $52M
- Stage
- Series D
- Announced
- 5 October 2026
- Lead
- Cook Medical
- Other investors
- ClavystBio, Invus Opportunities, F-Prime, Medtech Venture Partners
- Use of funds
- Accelerate the commercial launch of the Zenflow Spring System following FDA PMA approval.
- Checked
- Announced by the company